| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $615K | -34.1% | -63.1% |
| R&D Expense | $10.8M | -11.8% | -17.0% |
| SG&A Expense | $5.3M | -20.8% | -31.4% |
| Operating Income | -$15.4M | +14.0% | +92.3% |
| Pre-tax Income | -$24.3M | +8.4% | +87.9% |
| Income Tax | -$6K | -122.2% | -146.2% |
| Net Income | -$23.5M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $23.9M | -34.5% | -17.1% |
| Accounts Receivable | $604K | -36.6% | -49.2% |
| Current Assets | $26.2M | -34.1% | -16.9% |
| Total Assets | $330.2M | -4.6% | -10.2% |
| Current Liabilities | $20.6M | -8.3% | -6.2% |
| Long-term Debt |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$37.2M | — | — |
| Capital Expenditures | $492K | — | — |
| Investing Cash Flow | -$492K | — | — |
| Financing Cash Flow | $47.1M | — | — |
| Free Cash Flow | -$37.7M | — | — |
| +7.2% |
| +86.9% |
| EPS (Basic) | -$0.44 | +27.9% | +94.2% |
| EPS (Diluted) | -$0.44 | +27.9% | +94.2% |
| $116K |
| -17.1% |
| -60.1% |
| Total Liabilities | $278.2M | +2.4% | +12.6% |
| Stockholders' Equity | $50.4M | -30.1% | -53.4% |